Babita Yadav

ORCID: 0000-0003-4524-2452
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Phytochemicals and Medicinal Plants
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Blockchain Technology Applications and Security
  • Drug-Induced Hepatotoxicity and Protection
  • Allergic Rhinitis and Sensitization
  • COVID-19 and Mental Health
  • Artificial Intelligence in Healthcare
  • Liver Disease and Transplantation
  • Complementary and Alternative Medicine Studies
  • Liver Disease Diagnosis and Treatment
  • IoT and Edge/Fog Computing
  • Health, psychology, and well-being
  • Sinusitis and nasal conditions
  • Asthma and respiratory diseases
  • User Authentication and Security Systems
  • Pharmacological Effects of Medicinal Plants
  • COVID-19 Pandemic Impacts
  • Mindfulness and Compassion Interventions
  • Respiratory and Cough-Related Research
  • Long-Term Effects of COVID-19
  • Internet of Things and AI
  • Food Science and Nutritional Studies
  • Natural Antidiabetic Agents Studies
  • Nasal Surgery and Airway Studies

Central Council for Research in Ayurvedic Science
2020-2025

MVN University
2017-2024

Central Drug Research Institute
2021-2024

Hindustan Institute of Technology and Science
2024

Academy of Scientific and Innovative Research
2024

Government of India
2020-2023

Ministry of AYUSH
2020-2023

University of Allahabad
2023

Vardhman Mahavir Medical College & Safdarjung Hospital
2022

Central University of Himachal Pradesh
2022

Objective Evaluate the efficacy of AYUSH 64, a standard polyherbal Ayurvedic drug in COVID-19. Methods During first pandemic wave, 140 consenting and eligible hospitalized adult participants with mild-moderate symptomatic disease (specific RT-PCR assay positive) were selected as per convenience sample, randomized (1:1 ratio) to an open-label (assessor blind) two-arm multicentric trial; care (SOC Indian guidelines) versus 64 combined SOC (AYUSH plus). Participants assessed daily discharged...

10.1371/journal.pone.0282688 article EN cc-by PLoS ONE 2023-03-16

Hypertension presents as a modifiable risk factor for cardiovascular diseases, with approximately two-thirds of the global hypertensive population concentrated in low- and middle-income nations. Sarpagandha Mishran is an Ayurveda intervention utilized management hypertension. The objective study to assess clinical efficacy safety Sarpgandha Management Stage-I Hypertension. This trial employs prospective design characterized by double-dummy, double-blind, placebo-controlled methodology being...

10.1186/s12906-025-04802-4 article EN cc-by-nc-nd BMC Complementary Medicine and Therapies 2025-03-01

The escalating complexity and frequency of cyber threats have exposed the limitations traditional reactive cybersecurity measures, necessitating a shift toward proactive predictive defence strategies. This research paper presents comprehensive framework that integrates threat analysis behavior to address dynamic evolving nature modern risks. By combining advanced analytical techniques, such as time-series machine learning, with insights from behavioral psychology, this study aims enhance...

10.46647/ijetms.2025.v09si01.010 article EN International Journal of Engineering Technology and Management Sciences 2025-01-01

The rapid evolution of cyber threats, characterized by increasing sophistication and complexity, hasunderscored the critical need for robust methodologies in data collection analysis to enableproactive cybersecurity defences. This study delves into intricate processes cutting-edgetechnologies involved threat analysis, emphasizing their pivotalrole identifying, categorizing, mitigating risks. By leveraging a diverse array datasources, advanced analytical techniques, machine learning models,...

10.46647/ijetms.2025.v09si01.024 article EN International Journal of Engineering Technology and Management Sciences 2025-01-01

ABSTRACT Objectives To compare the co-administration of an Ayurvedic drug AYUSH 64 as adjunct to standard care (SOC) and SOC for efficacy safety in management COVID-19. Design Multicentre, parallel efficacy, randomized, controlled, open label, assessor blind, exploratory trial with a convenience sample. Patients followed complete 12 weeks study duration. Setting COVID-19 dedicated non-intensive wards at 1 government hospital, medical college teaching hospital university Participants 140...

10.1101/2021.06.12.21258345 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-06-17

Ayurveda interventions have been used for prophylaxis and care during the COVID-19 pandemic in India shown promising results promoting early clinical recovery from COVID-19.

10.1016/j.ctim.2023.102966 article EN cc-by-nc-nd Complementary Therapies in Medicine 2023-07-22

Abstract Background Coronavirus disease 2019 (Covid-19) occurs after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are at high risk of exposure, the standard care is personal protection from getting infected. Whether Ayurvedic rasayana drug like Chyawanprash can prevent symptomatic infection in frontline health workers unknown. Objective To evaluate effect combination and Standard Preventive Regimen compared use alone on proportion RT-PCR confirmed...

10.1101/2021.02.17.21251899 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-02-19

Introduction Vaccines have emerged as the most effective tool in fight against COVID-19. Governments all over world rolled out COVID-19 vaccine program for their populations. Oxford-AstraZeneca (COVISHIELD™) is widely used India. A large number of Indian people been consuming various traditional medicines hope better protection infection. Several studies reported immunological benefits Withania somnifera (Ashwagandha) and its potential a adjuvant. We propose to study safety, immunogenicity...

10.3389/fmed.2022.761655 article EN cc-by Frontiers in Medicine 2022-02-16

Depression is a critical problem that can affect people in diverse ways. Various treatment are there to treat suffering from depression but challenge here predict those who doesn't even know they depression. So, among certain models prepared of which overview three major given this article: a) Using Machine learning classifiers and WEKA, b) Imaging methods, c) the Risk factors.

10.1109/ctceec.2017.8455078 article EN 2017 International Conference on Current Trends in Computer, Electrical, Electronics and Communication (CTCEEC) 2017-09-01

Currently, there is no approved treatment for the management of coronavirus disease (COVID-19). Drug repurposing existing medications could be a possible way to find out novel therapeutic entity combat COVID-19.To determine clinical efficacy and safety an Ayurveda intervention (Guduchighana Vati) in asymptomatic mild-to-moderate cases COVID-19.This was open-label randomized controlled pilot study with sample size 30 participants (15 each arm). The were or mild moderate COVID-19. Guduchighana...

10.4103/ayu.ayu_11_21 article EN AYU (An International Quarterly Journal of Research in Ayurveda) 2020-01-01

Microsatellites are small, repetitive sequences found all across the human genome. Microsatellite instability is phenomenon of variations in length microsatellites induced by insertion or deletion repeat units tumor tissue (MSI). MSI-type stomach malignancy has distinct genetic phenotypes and clinic pathological characteristics, stability influences whether not patients with gastric mesothelioma react to immunotherapy. As a result, determining MSI status prior surgery critical for developing...

10.1155/2022/1012684 article EN cc-by BioMed Research International 2022-07-04

ABSTRACT Introduction The government of India has rolled out COVID-19 vaccine program for individuals who are 18 years age and above priority is being given to the elderly, with morbidity. Oxford-AstraZeneca (COVISHIELD™) most widely used in India. A large number Indian people have been consuming various traditional medicines hope better protection against infection. Several studies reported immunological benefits Ashwagandha its potential as adjuvant. We plan study co-administration...

10.1101/2021.07.02.21259886 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-07-06

Objective: To assess the efficacy and safety of Chyawanprash in preventing SARS-CoV-2 infection among health care personnel working at COVID-19 isolation ward. Setting: A hospital designated as centre Delhi, India Participants: Apparently healthy workers (HCWs) age 20 to 60 years who were RT PCR negative asymptomatic but possibly had exposure active cases COVID- 19, with or without co-morbid conditions included. Pregnant lactating females, volunteers malignancy, uncontrolled blood sugar,...

10.5455/aam.73639 article EN cc-by Annals of Ayurvedic Medicine 2021-01-01

Abstract BACKGROUND: The symptoms of Allergic Rhinitis,resemble the clinical presentation Vataja Pratishyaya , a type narrated in Ayurveda classical texts. An exploratory study was planned to assess safety and potential effect combination therapy interventions, viz., Ayush VPR (a coded Ayurvedic formulation), Shirishadi Kwath ( Anubhoota Yoga ), Nasya (intranasal drug administration) with Anutaila . MATERIALS AND METHODS: an open-label, multicenter, prospective pre-test post-test design....

10.4103/jras.jras_40_23 article EN Journal of Research in Ayurvedic Sciences 2023-10-01
Coming Soon ...